GLP-1 receptor agonist toxicity
Background
- GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss
- Poison control centers have reported increasing inquiries related to possible overdoses
Clinical Features
Differential Diagnosis
Evaluation
Workup
Diagnosis
Management
- Symptomatic management
- Anti-nausa medications (e.g., zofran)
- Consider stopping other glucose-lowering (i.e, diabetic) medications